课题基金 / 基金详情

Studying how a general allosteric site regulates protein kinase function

Studying how a general allosteric site regulates protein kinase function
研究一般变构位点如何调节蛋白激酶功能
批准号:
8874171
负责人:
Terry Justin Rettenmaier
金额:
$1.53万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2015-08-31

项目摘要

项目成果

Terry Justin Rettenmaier的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):蛋白激酶的小分子抑制剂已经彻底改变了生物医学科学。临床上,蛋白激酶抑制剂迎来时代 通过改变各种癌症的护理标准来实现个性化医疗。在实验室中,蛋白激酶抑制剂作为研究工具的广泛使用极大地提高了我们对蛋白激酶在信号通路中作用的认识。然而,调节单个激酶功能的分子机制仍然知之甚少。鉴于激酶导向疗法已被证实的临床价值,对激酶调节机制的详细了解可以通过确定调节激酶功能的新方法来显着影响人类健康。该提案的长期目标是确定一般变构位点如何调节蛋白激酶的底物特异性和亚细胞定位。该提案重点关注蛋白激酶 PDK1,其中的变构位点(称为 PIF 口袋)是大多数 PDK1 底物磷酸化所必需的。 PIF 袋还可能促进癌细胞运动。我们的实验室最近发现了与细胞中 PIF 袋结合的小分子。我们假设这些 PIF 袋配体将破坏 PDK1 与其底物和效应蛋白子集之间的相互作用,从而提供一种快速且可逆的方式来扰乱 PIF 袋功能。这里提出的工作旨在使用我们的 PIF 袋配体 1) 研究 PIF 袋如何确定 PDK1 的底物特异性,2) 研究 PIF 袋如何促进癌细胞运动。为了实现第一个目标,我们将通过质谱法鉴定 PDK1 底物,并确定其磷酸化对我们的 PIF 袋配体的敏感性。为了实现第二个目标,我们将描述 PIF 口袋在 3D 培养中生长的高度侵袭性黑色素瘤细胞运动中的作用。这些研究将强调这种通用变构位点在调节蛋白激酶功能中的重要性。这一概念可能会改变激酶药物发现的格局,并导致新型激酶导向疗法的开发。
英文摘要
DESCRIPTION (provided by applicant): Small-molecule inhibitors of protein kinases have revolutionized biomedical science. In the clinic, protein kinase inhibitors have ushered in the era of personalized medicine by transforming the standard of care for a variety of cancers. At the bench, the widespread use of protein kinase inhibitors as research tools has significantly advanced our knowledge of the roles of protein kinases in signaling pathways. However, the molecular mechanisms that regulate the function of individual kinases remain poorly understood. Given the proven clinical value of kinase-directed therapeutics, a detailed understanding of kinase regulatory mechanisms can significantly impact human health by identifying new ways to modulate kinase function. The long-term goal of this proposal is to determine how a general allosteric site regulates the substrate specificity and subcellular localization of the protein kinases. This proposal focuses on the protein kinase PDK1 where this allosteric site, known as the PIF pocket, is required for the phosphorylation of most PDK1 substrates. The PIF pocket may also promote cancer cell motility. Our lab recently identified small molecules that bind to the PIF pocket in cells. We hypothesize that these PIF-pocket ligands will disrupt the interaction between PDK1 and a subset of its substrates and effector proteins, thereby granting a rapid and reversible way to perturb PIF pocket function. The work proposed here aims to use our PIF-pocket ligands 1) to study how the PIF pocket determines the substrate specificity of PDK1 and 2) to study how the PIF pocket promotes cancer cell motility. To accomplish the first aim, we will identify PDK1 substrates by mass spectrometry and determine the sensitivity of their phosphorylation to our PIF-pocket ligands. To accomplish the second aim, we will characterize the role of the PIF pocket in the motility of highly aggressive melanoma cells grown in 3D culture. These studies will highlight the importance of this general allosteric site in regulating protein kinase function. This concept may alter the landscape of kinase drug discovery and lead to the development of a new class of kinase-directed therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of druggable pathways that prevent cell death caused by proteotoxic stress
Studying how a general allosteric site regulates protein kinase function
Studying how a general allosteric site regulates protein kinase function
海外基金